Qilian Mixture as an Adjunct Treatment During Gefitinib Therapy in Lung Adenocarcinoma Patients: A Randomized Controlled Clinical Trial With Mechanism Exploration
Qilian Mixture as an Adjunct Treatment During Gefitinib Therapy in Lung Adenocarcinoma Patients: A Randomized Controlled Clinical Trial With Mechanism Exploration
Zhaoshui Li, Xin Zheng, Ting Jiang
Journal
Asia-Pacific Journal of Clinical Oncology
Topics
Microbial Metabolism and Applications
article
Qilian Mixture as an Adjunct Treatment During Gefitinib Therapy in Lung Adenocarcinoma Patients: A Randomized Controlled Clinical Trial With Mechanism Exploration
Zhaoshui Li, Xin Zheng, Ting Jiang
article en
Abstract
No abstract available for this paper.
Publication Tag
Asia-Pacific Journal of Clinical Oncology
Institutions
Qingdao University (CN), Shandong Provincial Hospital (CN), Affiliated Hospital of Qingdao University (CN), Shandong First Medical University (CN)
Funders
National Natural Science Foundation of China, Natural Science Foundation of Shandong Province